| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US13072899P | 1999-04-22 | 1999-04-22 | |
| US60130728 | 1999-04-22 | ||
| PCT/US2000/010696WO2000064516A1 (en) | 1999-04-22 | 2000-04-19 | Controlled delivery of bisphosphonates |
| Publication Number | Publication Date |
|---|---|
| AU4652100Atrue AU4652100A (en) | 2000-11-10 |
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU46521/00AAbandonedAU4652100A (en) | 1999-04-22 | 2000-04-19 | Controlled delivery of bisphosphonates |
| Country | Link |
|---|---|
| EP (1) | EP1210138A4 (en) |
| AU (1) | AU4652100A (en) |
| CA (1) | CA2370769A1 (en) |
| WO (1) | WO2000064516A1 (en) |
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6984400B2 (en) | 1998-07-14 | 2006-01-10 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Method of treating restenosis using bisphosphonate nanoparticles |
| IL125336A0 (en) | 1998-07-14 | 1999-03-12 | Yissum Res Dev Co | Compositions for inhibition and treatment of restinosis |
| US7008645B2 (en) | 1998-07-14 | 2006-03-07 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Method of inhibiting restenosis using bisphosphonates |
| FR2803521B1 (en)* | 2000-01-12 | 2002-10-25 | Ceva Sante Animale | USE OF TILUDRONIC ACID AND ITS DERIVATIVES IN POULTRY FOR THE PREPARATION OF A MEDICINAL PRODUCT FOR PREVENTING AND TREATING OSTEOPOROSIS |
| US7829074B2 (en) | 2001-10-18 | 2010-11-09 | Nektar Therapeutics | Hydroxypatite-targeting poly(ethylene glycol) and related polymers |
| US20020151876A1 (en)* | 2001-02-07 | 2002-10-17 | Tai-Wah Chan | Devices and methods for management of bone density |
| KR20020080018A (en)* | 2001-04-10 | 2002-10-23 | 한국화학연구원 | A controlled/sustained implant delivery containing bisphosphonate |
| US10517883B2 (en) | 2003-06-27 | 2019-12-31 | Zuli Holdings Ltd. | Method of treating acute myocardial infarction |
| FI20031120A0 (en)* | 2003-07-31 | 2003-07-31 | Bci Bioabsorbable Concepts Ltd | Multifunctional implant device |
| EP1508343B1 (en)* | 2003-08-21 | 2015-11-04 | AddBIO AB | Bisphosponate coated implant device and method therefor |
| WO2010111627A1 (en)* | 2009-03-26 | 2010-09-30 | Psivida Us, Inc. | Implantable formulations of bisphosphonic acids |
| CN102573809B (en) | 2009-07-31 | 2017-07-21 | 格兰泰股份有限公司 | Method for crystallising and bioavilability |
| US9169279B2 (en) | 2009-07-31 | 2015-10-27 | Thar Pharmaceuticals, Inc. | Crystallization method and bioavailability |
| US20160016982A1 (en) | 2009-07-31 | 2016-01-21 | Thar Pharmaceuticals, Inc. | Crystallization method and bioavailability |
| US20130064861A1 (en)* | 2010-02-17 | 2013-03-14 | Zvi Schwartz | Compositions and methods for modifying in vivo calcification of hydrogels |
| US9340565B2 (en) | 2010-11-24 | 2016-05-17 | Thar Pharmaceuticals, Inc. | Crystalline forms |
| US9993427B2 (en) | 2013-03-14 | 2018-06-12 | Biorest Ltd. | Liposome formulation and manufacture |
| JO3394B1 (en)* | 2014-07-04 | 2019-10-20 | Osteo Pharma B V | Compositions and products for use in the treatment of bone fractures and defects |
| US10195218B2 (en) | 2016-05-31 | 2019-02-05 | Grunenthal Gmbh | Crystallization method and bioavailability |
| US12377149B2 (en)* | 2018-06-01 | 2025-08-05 | The University Of North Carolina At Chapel Hill | Injectable thermoresponsive hydrogels as a combinatory modality for controlled drug delivery, biomaterial implant and 3D printing bioink |
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4753652A (en)* | 1984-05-04 | 1988-06-28 | Children's Medical Center Corporation | Biomaterial implants which resist calcification |
| US5196409A (en)* | 1989-08-20 | 1993-03-23 | Yissum, Research Development Company Of The Hebrew University Of Jerusalem | Bisphosphonates, pharmaceutical compositions, and process for the treatment of irregularities in calcium metabolism |
| CA2151240A1 (en)* | 1992-12-23 | 1994-07-07 | Donna T. Whiteford | Biophosphonate/estrogen therapy for treating and preventing bone loss |
| FI92465C (en)* | 1993-04-14 | 1994-11-25 | Risto Tapani Lehtinen | A method for handling endo-osteal materials |
| US5646134A (en)* | 1994-04-21 | 1997-07-08 | Merck & Co., Inc. | Alendronate therapy to prevent loosening of, or pain associated with, orthopedic implant devices |
| JP3476930B2 (en)* | 1994-11-16 | 2003-12-10 | オリンパス株式会社 | Biological implants |
| EP0831756A1 (en)* | 1995-06-06 | 1998-04-01 | Merck & Co., Inc. | Bisphosphonate cement composition to prevent aseptic loosening of orthopedic implant devices |
| US5898038A (en)* | 1996-03-19 | 1999-04-27 | Board Of Regents, The University Of Texas System | Treatment of osteoporosis and metabolic bone disorders with nitric oxide substrate and/or donors |
| GB2324726A (en)* | 1997-05-01 | 1998-11-04 | Merck & Co Inc | Combination Therapy for the Treatment of Osteoporosis |
| Publication number | Publication date |
|---|---|
| EP1210138A4 (en) | 2003-05-07 |
| CA2370769A1 (en) | 2000-11-02 |
| EP1210138A1 (en) | 2002-06-05 |
| WO2000064516A1 (en) | 2000-11-02 |
| Publication | Publication Date | Title |
|---|---|---|
| AU5914999A (en) | Controlled release drug delivery | |
| AU4652100A (en) | Controlled delivery of bisphosphonates | |
| AU2492000A (en) | Implantable neuro-stimulator | |
| AU3342599A (en) | Delivery catheter | |
| AU6168699A (en) | Non-compliant system for delivery of implant material | |
| AU5588499A (en) | Implant delivery assembly | |
| AU4981200A (en) | Stent delivery system | |
| AU5259100A (en) | Medicament | |
| AU4139801A (en) | Controlled delivery of antigens | |
| AU7059300A (en) | Immediate provisional implant | |
| AU6956398A (en) | Implant delivery system | |
| AU3007801A (en) | Medicament dispenser | |
| AU2509901A (en) | Medicament dispenser | |
| AU2212300A (en) | Delivery vault | |
| AU6109400A (en) | Atomizer system | |
| AU3520900A (en) | Implantable drug delivery system | |
| AU1514401A (en) | Medicament dispenser | |
| AU7003500A (en) | Delivery box | |
| AU5092099A (en) | Vibroacoustic delivery system | |
| AU1541601A (en) | Syringes | |
| AU5003800A (en) | Implant system | |
| AU2331100A (en) | Ceramic coating | |
| AU5429699A (en) | Drug targeting | |
| AU5745900A (en) | Suspoemulsion system for delivery of actives | |
| AUPQ067299A0 (en) | Atomiser |
| Date | Code | Title | Description |
|---|---|---|---|
| MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |